BeStock  
Stocks › Biotechnology › DNLI

Denali Therapeutics DNLI

US equityMarket cap rank #2440Biotechnology
$18.45 +$0.25 (+1.37%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $18.45 0.00%
Open$17.97
Prev close$18.20
Day range$17.92 – $18.85
Volume2.63M
Market cap$2.96B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts7
Average target$35.33+91.5% vs. price
  • Buy 100%
Low $24.00Now $18.45Avg $35.33High $42.00

Recent rating changes

The last 20 actions on file set price targets from $24.00 to $42.00, averaging $36.18.

DateFirmRatingTarget
13 Nov 2026 Wells Fargo BUY $35.00
13 Nov 2026 Morgan Stanley BUY $37.00
4 Nov 2026 BofA Securities BUY –
4 Nov 2026 Wedbush BUY $24.00
4 Nov 2026 Morgan Stanley BUY $42.00
4 Nov 2026 B. Riley Securities BUY $35.00
4 Nov 2026 H.C. Wainwright BUY $42.00
3 Nov 2026 BTIG BUY $39.00
25 Aug 2026 B. Riley Securities BUY $35.00
11 Aug 2026 J.P. Morgan BUY $29.00
7 Aug 2026 William Blair BUY –
7 Aug 2026 UBS BUY $34.00
7 Aug 2026 BofA Securities BUY $31.00
7 Aug 2026 Baird BUY $34.00
7 Aug 2026 Morgan Stanley BUY $40.00
7 Aug 2026 Stifel BUY $41.00
7 Aug 2026 H.C. Wainwright BUY $42.00
6 Aug 2026 TD Cowen BUY –
6 Aug 2026 BTIG BUY $39.00
23 Jul 2026 Morgan Stanley BUY $36.00

Discussion

No comments yet — be the first to weigh in on DNLI.

Sign in to join the discussion.

Scroll to Top